Effects of oxytocin treatment in boys with autism with and without intellectual disability: a verification trial with long-term follow-up
Oxytocin therapy in children with autism spectrum disorder and co-occurring intellectual disability: examination of desirability, clinical efficacy and therapeutic augmentation by psychosocial training
Endogenous oxytocin levels in children with autism : associations with cortisol levels and oxytocin receptor gene methylation
Is paternal oxytocin an oxymoron? Oxytocin, vasopressin, testosterone, oestradiol and cortisol in emerging fatherhood
Changes in endogenous oxytocin levels after intranasal oxytocin treatment in adult men with autism: An exploratory study with long-term follow-up
Amygdala–Hippocampal Connectivity Is Associated With Endogenous Levels of Oxytocin and Can Be Altered by Exogenously Administered Oxytocin in Adults With Autism
Anti-depressant-like effects of oxytocin in mice are dependent on the presence of insulin-regulated aminopeptidase.
3-(Benzylamino)-4-(cyclohexylamino)-n-(2-(piperazin-1-yl)ethyl)benzenesulfonamide derivatives and related ferrostatin-1 analogues as cell death inhibitors for treating e.g. Stroke
3-(benzylamino)-4-(cyclohexylamino)-n-(2-(piperazin-1-yl)ethyl)benzenesulfonamide derivatives and related ferrostatin-1 analogues as cell death inhibitors for treating e.G. stroke